MANAGE DS NISSANKA

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry SOUTH WINDSOR, CT NPI 1477535540

General Payments — all program years on this page

$3,768.11

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,187.18 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,187.1811

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ITI, Inc. $381.664
Alkermes, Inc. $309.043
Otsuka America Pharmaceutical, Inc. $251.212
Teva Pharmaceuticals USA, Inc. $245.272

By program year

Program yearAmountRecords
2018 $726.436
2019 $239.782
2020 $69.191
2021 $356.813
2022 $498.755
2023 $689.976
2024 $1,187.1811

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1118951974 Otsuka America Pharmaceutical, Inc. $126.21 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118951976 Otsuka America Pharmaceutical, Inc. $125.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120563406 Alkermes, Inc. $99.48 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120563408 Alkermes, Inc. $97.64 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120563410 Alkermes, Inc. $111.92 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143287817 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $117.92 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143287821 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.98 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143287825 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.88 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143287829 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.88 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151536933 Teva Pharmaceuticals USA, Inc. $114.57 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151537041 Teva Pharmaceuticals USA, Inc. $130.70 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.